Equities

ALT

AU000000ALT0

Medical Equipment, Supplies & Distribution

Delayed Australian S.E. Other stock markets 10:02:57 28/02/2023 am IST			5-day change	1st Jan Change
0.001 ^AUD	-.--%		-.--%	-.--%

2023	Analytica Appoints Voluntary Administrators	MT
2023	Analytica CEO Resigns	MT

Analytica Limited Reports Earnings Results for the Full Year Ended June 30, 2020

August 31, 2020 at 05:08 am IST

Analytica Limited announced earnings results for the full year ended June 30, 2020. For the full year, the company announced sales was AUD 11,367 compared to AUD 54,805 a year ago. Net loss was AUD 1.620 million compared to AUD 2.054 million a year ago. Basic loss per share was AUD 0.0005 compared to AUD 0.0006 a year ago.

Latest news about ANALYTICA

Analytica Appoints Voluntary Administrators	13/23/13	MT
Analytica CEO Resigns	12/23/12	MT
Dr Michael Monsour Will Take on the Role of Executive Chairman of Analytica Limited	12/23/12	CI
Analytica Limited Announces Resignation of Geoff Daly as CEO	12/23/12	CI
Analytica Limited Reports Earnings Results for the Half Year Ended December 31, 2022	28/23/28	CI
Analytica Limited Reports Earnings Results for the Full Year Ended June 30, 2022	31/22/31	CI
Analytica Limited Auditor Raises 'Going Concern' Doubt	31/22/31	CI
Analytica Secures Canadian Patent for Pelvic Floor Exercise System	13/22/13	MT
Analytica Secures European, Indian Patent for Training Device	18/22/18	MT
Analytica Limited Reports Earnings Results for the Half Year Ended December 31, 2021	23/22/23	CI
Analytica Secures US Patent for PeriCoach Device	11/21/11	MT
Analytica Limited Auditor Raises 'Going Concern' Doubt	30/21/30	CI
Analytica Limited Reports Earnings Results for the Full Year Ended June 30, 2021	31/21/31	CI
Analytica : Secures US Patent for Pelvic Floor Exercise System	30/21/30	MT
Analytica Announces Expansion of Enhanced Infusion System into Middle East	27/21/27	CI
Analytica : Plans Up to $3 Million Share Placement	23/21/23	MT
Analytica : Enters Deal to Distribute Intravenous Flow Monitoring Device in Middle East	20/21/20	MT
Analytica Limited Enters into Joint Venture Agreement to Manufacture, Distribute and Market the System in China, Macau, Hong Kong and Taiwan	31/21/31	CI
Analytica Limited Reports Earnings Results for the Second Quarter Ended December 31, 2020	26/21/26	CI
Analytica Ltd Announces Publication of an Independent Clinical Trial from the University of New Mexico in the Journal of Female Pelvic Medicine & Reconstructive Surgery, the Official Journal of the American Urogynecologic Society, Demonstrating PeriCoach Non-Inferiority to In- Clinic Pelvic Floor Physical Therapy	20/20/20	CI
Analytica Limited Reports Earnings Results for the Full Year Ended June 30, 2020	31/20/31	CI
Analytica Ltd Announces Resignation of Thomas Lönngren, Non-Executive Director	18/20/18	CI
Analytica Limited Reports Earnings Results for the Half Year Ended December 31, 2019	27/20/27	CI
Analytica Ltd Announces Middle East Distribution Agreement Supplementary Disclosure	13/19/13	CI
Analytica Ltd. Reports Earnings Results for the Full Year Ended June 30, 2019	23/19/23	CI

Chart ANALYTICA

Duration

Period

More charts

Company Profile

Analytica Limited is an Australia-based product development and commercialization company that is focused on Class I and II medical device products. Its lead product is the PeriCoach System- an e-health treatment system for women who suffer stress urinary incontinence. PeriCoach includes a device, Web portal and smartphone app and the device evaluates activity in pelvic floor muscles. This information is transmitted to a smartphone app and can be loaded to a cloud database where physicians can monitor patient progress via Web portal. The Company is also the developer of the Enhanced Infusion System (EIS), a combination of technologies developed under the project names AutoStart and AutoFlush. It is also commercializing the AutoStart Burette infusion system. The EIS is a simple and inexpensive IV add-in technology to reduce nursing monitoring costs, reduce embolism risk, improve infection control and automatically restart flow after medication delivery during intravenous fluid infusion.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ANALYTICA	-.--%	3.06M
ABBOTT LABORATORIES	-4.72%	184B
MEDTRONIC PLC	-2.83%	103B
BECTON, DICKINSON AND COMPANY	-5.01%	67.59B
CENCORA, INC.	+15.53%	46.93B
DEXCOM, INC.	-8.53%	43.87B
HOYA CORPORATION	+6.33%	41.2B
METTLER-TOLEDO INTERNATIONAL, INC.	+17.67%	30.47B
TERUMO CORPORATION	+12.12%	24.16B
WEST PHARMACEUTICAL SERVICES, INC.	-8.08%	23.57B

Other Medical Equipment, Supplies & Distribution